CN118121524B - Acne-removing facial cleanser composition and bath foam thereof - Google Patents
Acne-removing facial cleanser composition and bath foam thereof Download PDFInfo
- Publication number
- CN118121524B CN118121524B CN202410551852.3A CN202410551852A CN118121524B CN 118121524 B CN118121524 B CN 118121524B CN 202410551852 A CN202410551852 A CN 202410551852A CN 118121524 B CN118121524 B CN 118121524B
- Authority
- CN
- China
- Prior art keywords
- acne
- parts
- extract
- agent
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract description 56
- 206010000496 acne Diseases 0.000 title abstract description 56
- 239000000203 mixture Substances 0.000 title abstract description 28
- 230000001815 facial effect Effects 0.000 title abstract description 22
- 239000006260 foam Substances 0.000 title description 19
- 238000012360 testing method Methods 0.000 abstract description 34
- 239000002537 cosmetic Substances 0.000 abstract description 27
- 239000000284 extract Substances 0.000 abstract description 26
- 238000004140 cleaning Methods 0.000 abstract description 15
- 229920000858 Cyclodextrin Polymers 0.000 abstract description 8
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract description 8
- 241000628997 Flos Species 0.000 abstract description 6
- 241001506047 Tremella Species 0.000 abstract description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract description 6
- 239000001140 aloe barbadensis leaf extract Substances 0.000 abstract description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract description 3
- 229960004889 salicylic acid Drugs 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 48
- 230000000694 effects Effects 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000003795 chemical substances by application Substances 0.000 description 16
- 239000000523 sample Substances 0.000 description 14
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 12
- 230000003020 moisturizing effect Effects 0.000 description 12
- 239000000811 xylitol Substances 0.000 description 12
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 12
- 229960002675 xylitol Drugs 0.000 description 12
- 235000010447 xylitol Nutrition 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000012459 cleaning agent Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 7
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 229930182478 glucoside Natural products 0.000 description 6
- 150000008131 glucosides Chemical class 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 4
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 4
- 240000002129 Malva sylvestris Species 0.000 description 4
- 235000006770 Malva sylvestris Nutrition 0.000 description 4
- 244000042664 Matricaria chamomilla Species 0.000 description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 4
- 244000236658 Paeonia lactiflora Species 0.000 description 4
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- -1 etc. Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 108700004121 sarkosyl Proteins 0.000 description 4
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- 208000020154 Acnes Diseases 0.000 description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 3
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000020691 dandelion extract Nutrition 0.000 description 3
- 229940073499 decyl glucoside Drugs 0.000 description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229940084032 paeonia lactiflora root extract Drugs 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000036555 skin type Effects 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000003749 cleanliness Effects 0.000 description 2
- 229940067866 dandelion extract Drugs 0.000 description 2
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000008233 hard water Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000001845 taraxacum officinale leaf extract Substances 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LTBAFRQKFIMYQK-DLWPFLMGSA-N (2s,3r,4r)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentane-1,2,3,4-tetrol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LTBAFRQKFIMYQK-DLWPFLMGSA-N 0.000 description 1
- JLEPZAUPTZFVIM-RHIZIOMBSA-N (3s,5s,9r,10s,13r,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-1,2,3,4,5,6,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthrene-14-carbaldehyde Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CCC33C=O)C)C3=CC[C@H]21 JLEPZAUPTZFVIM-RHIZIOMBSA-N 0.000 description 1
- ZDSCFBCGDDCJFZ-UHFFFAOYSA-N 2-(methylamino)ethanesulfonic acid;sodium Chemical compound [Na].CNCCS(O)(=O)=O ZDSCFBCGDDCJFZ-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000245665 Taraxacum Species 0.000 description 1
- 241000292546 Taraxacum mongolicum Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 241000908178 Tremella fuciformis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- GOJYXPWOUJYXJC-UHFFFAOYSA-M sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O GOJYXPWOUJYXJC-UHFFFAOYSA-M 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of cosmetics, in particular to an acne-removing facial cleanser composition and shower gel thereof. It comprises salicylic acid, cyclodextrin, flos Chrysanthemi Indici extract, herba Taraxaci extract, radix Paeoniae extract, flos Matricariae Chamomillae extract, flos Mali Pumilae extract, aloe vera leaf juice, tremella fruiting body extract, etc. The shower gel disclosed by the invention has excellent cleaning and acne removing performances. The body wash has no obvious reddening, mild and no stimulation in the body wash patch test.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to an acne-removing facial cleanser composition and shower gel thereof.
Background
Along with the acceleration of modern life rhythm and the improvement of health consciousness of people, the quality and performance of the shower gel are increasingly focused by consumers as an indispensable cleaning product in daily life. Although the traditional surfactant bath cream can meet the basic cleaning requirement, the traditional surfactant bath cream cannot meet the pursuit of modern people on life quality due to various problems in the use process, such as uncleanness in washing, trace toxic substances generation and the like. The fatty acid soap base type bath lotion has better flushing property, but has over-strong alkalinity, is easy to cause irritation to skin, makes the skin feel dry and tight, even causes itching, causes inflammation, red swelling and the like. Therefore, developing a shower gel which is mild in performance, good in flushing performance, and capable of removing acnes at the same time, and capable of cleaning the face becomes a new market demand.
Disclosure of Invention
In order to achieve the aim of the invention, the invention provides an acne-removing facial cleanser composition, which comprises an acne-removing agent, a conditioner and a cleanser.
The acne removing agent comprises the following main components:
Salicylic acid (SALICYLIC ACID) has very wide application in cosmetics, and has the effects of cleaning, removing cutin, removing acne, shrinking pores, tightening skin, whitening skin, brightening skin and the like because of the special lipid solubility, antibiosis, anti-inflammatory, skin cell renewal stimulation, melanin formation inhibition and the like.
CYCLODEXTRIN (CYCLODEXTRIN), a cyclic oligomer formed by specific fermentation of starch, can form a water-soluble inclusion compound with various lipophilic substances, so that the solubility of the substances in water is improved, and on the basis of the CYCLODEXTRIN, CYCLODEXTRIN is commonly used as a transmission medium to increase the transdermal absorption capacity of cosmetics, and has a certain antibacterial and anti-aging effects, so that the CYCLODEXTRIN is widely applied to the cosmetics.
The wild chrysanthemum flower (CHRYSANTHEMUM INDICUM) flower extract is extracted from the corolla part of wild chrysanthemum flower, is a natural active ingredient widely applied to cosmetics and health products, mainly plays the role of skin conditioning agent in skin care cosmetics, has the effects of resisting oxidation and inflammation, can be used for treating symptoms such as skin itch and eczema, can avoid skin dryness and can prevent skin aging.
Herba Taraxaci (TARAXACUM MONGOLICUM) extract is prepared from herba Taraxaci by concentrating, spray drying, and other processes. Mainly contains dandelion sterol, choline, inulin, pectin and other components. In the field of cosmetics, dandelion extracts can be used for preparing facial masks, face creams, essence and the like due to the effects of anti-inflammatory, antioxidation, moisturizing and the like, and are beneficial to improving skin states and increasing skin elasticity and luster.
Paeonia lactiflora (PAEONIA LACTIFLORA) root extract, paeonia lactiflora root extract, i.e. Paeonia lactiflora root, is the root of Paeonia lactiflora of Ranunculaceae, and has high medicinal value. It has strong antibacterial effect, and can inhibit elastase activity, promote fibroblast activity, eliminate free radical, and promote cathepsin activity, and the radix Paeoniae extract has skin activating and antiaging effects, and can be used in cosmetics. In addition, the paeonia lactiflora root extract can be used as a humectant, an antiallergic agent and an anti-inflammatory agent, and has remarkable effects on moisturizing, antiallergic and anti-inflammatory of skin.
The conditioning agent comprises:
The active ingredient extracted from the chamomile (chamomile) which is an extract of chamomile (CHAMOMILLA RECUTITA) has various effects and wide application fields. The flos Matricariae Chamomillae extract is rich in volatile oil, flavonoids, amino acids, chlorogenic acid and microelements, and the components endow the flos Matricariae Chamomillae extract with antibacterial, antioxidant, antiinflammatory, relieving and antiallergic biological activities. Can be used as nutritional additive for preventing allergy, keeping moisture, preventing acne, and resisting aging. In addition, the skin moisturizing agent can be used for moisturizing a large amount of skin, reducing fine wrinkles, relieving the skin, resisting skin sensitivity, effectively supplementing water to the skin, enabling the skin to be in a relatively stable state and reducing the problem of redness of the skin.
The flower extract of Malva sylvestris (MALVA SYLVESTRIS) is a natural plant extract and contains rich flavonoid, polysaccharide, organic acid and other components.
Aloe vera (Aloe BARBADENSIS) leaf juice is a natural plant extract and has various effects and application fields. Can be directly used for skin care, such as anti-inflammation, sterilizing, and relieving mosquito bite or local pruritus. Meanwhile, the skin care product can also be prepared to provide skin with moisture.
Tremella (TREMELLA FUCIFORMIS) fruiting body extract: the tremella fruit body extract has wide application in the cosmetic field. The skin-care product can form a protective film to cover the surface of the skin, plays a role in moisturizing and nourishing, and effectively relieves skin dryness and moisture loss. In addition, the product has the effects of resisting inflammation, detumescence, whitening skin, reducing speckle, enhancing cellular immunity, scavenging free radicals, resisting oxidation, and resisting aging. These effects are mainly due to the active ingredients in tremella fruit body extract, such as colloid substances, amino acids, multiple vitamins, etc.
Xylitol-based glucoside (XYLITYLGLUCOSIDE), a glycan consisting of xylitol and glucoside. It has a variety of unique properties and a wide range of applications. Xylitol-based glucosides are a common ingredient in cosmetic and personal care products. It can be used as humectant to form a moisturizing film, reduce water loss, and increase skin water retention. Meanwhile, the anti-aging agent also has an anti-oxidation effect, can neutralize free radicals, reduce skin damage and achieve an anti-aging effect. In addition, xylitol-based glucoside can also regulate skin pH value, reduce skin sensitivity to external stimulus, and relieve skin.
Xylitol (XYLITOL): xylitol is an organic compound, also known as methylaldehyde or papaya sugar alcohol, and has the chemical formula C 5H12O5. Is native to Finnish, and can be extracted from plant materials such as birch, oak, corncob, bagasse, etc., and xylitol has effects of keeping moisture, resisting oxidation, and relieving inflammation in cosmetic field.
The cleaning agent comprises:
Ammonium laureth sulfate (Laureth Sulfate Ammonium): a compound is prepared from laureth and sulfuric acid. It has good solubility and can form transparent solution in water. Is widely used in shampoo, foam bath, shower foam and other preparations requiring high foam and good skin tolerance.
Cocamidopropyl betaine (Cocoamidopropyl Betaine): a mild amphoteric surfactant is derived from coconut oil. Has good synergistic effect, can reduce the irritation generated by the traditional surfactant, improve the foaming force and generate fine, stable and rich foam. In addition, it has thickening effect and less skin irritation.
Sodium lauroyl sarcosinate (sodium N-lauroylsarcosinate): a white to pale yellow liquid has special smell, and is dissolved in water, ethanol or glycerol. Has less skin irritation and weak degreasing effect, and is stable to heat, acid and alkali.
Lauroyl amphoacetate sodium (sodium lauroamphoacetate): the amphoteric ion surfactant is colorless to amber viscous liquid, has low irritation to skin and eyes, and is a mild surfactant. Hard water resistance, and makes the foam rich, fine and stable.
Sodium cocoyl methyl taurate (SODIUM METHYL COCOYL TAURATE): a novel amino acid surfactant is prepared by condensing natural fatty acid and sodium methyltaurine. Has very little irritation to skin. Is often used for preparing various high-grade cosmetics, infant products, facial cleanser, foam bath lotion and the like.
Decyl glucoside (n-Decyl glucoside): also called n-decyl glucoside, is one of novel nonionic surfactants APG. It is easy to dissolve in water, low in surface tension, rich in foam, fine and stable, non-toxic, harmless, non-irritating and quick in biological degradation. Has excellent washing, wetting, emulsifying and dispersing abilities, and is a green surfactant with comprehensive performance.
The acne-removing facial cleanser is prepared by compounding an acne-removing agent, a conditioner and a cleaning agent. Experiments prove that the acne-removing agent, the conditioner and the cleaning agent interact with each other to play a role in synergy, so that the acne-removing facial cleaning composition has better efficacy.
Preferably, the acne-removing cleansing composition comprises the following raw materials in percentage by mass: 1-1.5 parts of acne removing agent, 0.4-1 part of conditioner and 27-30 parts of cleaning agent.
Preferably, the acne removing agent comprises the following raw materials in parts by mass: 5.8-7 parts of salicylic acid; 0.4-1 part of cyclodextrin; 0.6-1 part of wild chrysanthemum extract; 0.6-1 part of dandelion extract; 0.6-1 part of paeonia lactiflora root extract.
Preferably, the conditioning agent comprises the following raw materials in parts by mass: 0.3-1 part of chamomile extract; 0.3-1 part of Malva sylvestris extract; 1.8-2 parts of aloe vera leaf juice; 3.5-4 parts of tremella fruit body extract; xylitol-based glucoside 0.045-0.05; xylitol 0.035-0.05.
Preferably, the cleaning agent comprises the following raw materials in percentage by mass: 10.5-11 parts of laureth ammonium sulfate; 1.05-1.1 parts of cocamidopropyl betaine; 0.9-1 part of sodium lauroyl sarcosinate; 0.95-0.97 parts of lauroyl amphoacetate sodium; 0.35-0.4 part of cocoyl methyl taurine sodium; 0.55-0.7 part of decyl glucoside.
Preferably, the acne-removing cleansing composition further comprises a preservative, a thickener and a chelating agent, wherein the preservative is phenoxyethanol and/or sodium benzoate; the thickener is sodium chloride; the chelating agent is disodium EDTA.
Preferably, the preservative is a mixed solution of phenoxyethanol and sodium benzoate in any proportion.
Experiments show that when the acne removing agent, the conditioner and the cleaning agent are compounded according to the mass part ratio, the acne removing cleaning effect is better.
The invention also provides application of the acne-removing cleansing composition in cosmetics.
The invention also provides a cosmetic which contains the acne-removing cleansing composition. The cosmetic can be in the form of cream, lotion, essence, facial mask, bath lotion, etc., but is not limited thereto.
Preferably, the acne-removing cleansing composition comprises 20-40 wt% of cosmetics.
When the acne-removing facial cleaning composition is applied to cosmetics in the weight percentage, the acne-removing facial cleaning composition can provide cosmetics with better acne-removing facial cleaning effect.
Most preferably, the acne-removing cleansing composition comprises 35 weight percent of the acne-removing cleansing composition in cosmetics, and the acne-removing cleansing composition has the best acne-removing cleansing effect when added in the acne-removing cleansing composition.
When the acne-removing facial cleaning composition is applied to cosmetics in the weight percentage, the acne-removing facial cleaning effect of the cosmetics can be effectively improved.
The invention also provides acne-removing cleansing shower gel which comprises the following components in percentage by weight:
20% -45% of the acne-removing facial cleanser composition and the balance of water are filled. The acne-removing cleansing shower gel prepared by the formula disclosed by the invention is mild and free of irritation to skin, is safe to use, has excellent acne-removing cleansing efficacy, and is suitable for various skin types.
More preferably, the acne-removing cleansing composition bath cream comprises the following components in percentage by weight:
35% of the acne-removing cleansing composition and the balance of deionized water. The skin care product bath cream prepared by the formula is mild and has no stimulation to skin, is safe to use, has excellent acne-removing and face-cleaning effects, and is suitable for various skin types.
Preferably, the preparation method of the acne-removing facial cleansing shower gel comprises the following steps of:
s1, adding a cleaning agent and a chelating agent into water, heating to 80-85 ℃, stirring and cooling;
And S2, after cooling to 40-45 ℃, adding an acne removing agent, a conditioner, a preservative and a thickener into the S1, stirring and dissolving until the temperature is less than or equal to 38 ℃, and standing for 12 hours.
Compared with the prior art, the invention has the beneficial effects that; the invention creatively adds acne removing and skin conditioning components into the bath lotion, and improves the absorption of various natural product extracts and various beneficial components in the bath lotion while deeply cleaning.
Experiments show that the acne-removing facial cleanser composition can remove acnes caused by various reasons, has the effects of resisting inflammation, relieving, moisturizing and repairing, and is suitable for various skin types. The invention discovers that on the premise of the same usage amount, the acne removing agent, the conditioner, the cleanser and the internal components thereof with specific proportions have better effects of synergy compared with the single use or the common use of any three of the acne removing agent, the conditioner, the cleanser and the internal components thereof, so that the acne removing cleansing effect is better. The invention also provides a formula for ensuring that the acne-removing facial cleanser composition has better effect on acne-removing facial cleanser, and also provides a preferable formula for applying the acne-removing facial cleanser composition to bath foam.
Detailed Description
For a better illustration of the objects, technical solutions and advantages of the present invention, the present invention is further illustrated by the following examples. It should be understood that the embodiments of the present invention are only for illustrating the technical effects of the present invention, but not for limiting the scope of the present invention, and the methods used in the embodiments are conventional methods unless specifically described otherwise.
The sources of part of raw materials in the invention are as follows:
salicylic acid: purchased from ala Ding Shiji (Shanghai) limited.
Cyclodextrin: purchased from ala Ding Shiji (Shanghai) limited.
Wild chrysanthemum extract: purchased from western ampelopsis biotechnology limited.
Dandelion extract: purchased from western ampelopsis biotechnology limited.
Paeonia root extract: purchased from western ampelopsis biotechnology limited.
Flos Matricariae Chamomillae extract: purchased from western ampelopsis biotechnology limited.
An extract of malva sylvestris: purchased from western ampelopsis biotechnology limited.
Aloe vera leaf juice: purchased from western ampelopsis biotechnology limited.
Tremella fruit body extract: purchased from western ampelopsis biotechnology limited.
Xylitol-based glucoside: purchased from ala Ding Shiji (Shanghai) limited.
Xylitol: purchased from ala Ding Shiji (Shanghai) limited.
Ammonium laureth sulfate: purchased from ala Ding Shiji (Shanghai) limited.
Cocamidopropyl betaine: purchased from ala Ding Shiji (Shanghai) limited.
Sodium lauroyl sarcosinate: purchased from ala Ding Shiji (Shanghai) limited.
Lauroyl amphoacetate sodium: purchased from ala Ding Shiji (Shanghai) limited.
Sodium cocoyl methyl taurate: purchased from ala Ding Shiji (Shanghai) limited.
Decyl glucoside: purchased from ala Ding Shiji (Shanghai) limited.
Phenoxyethanol: purchased from ala Ding Shiji (Shanghai) limited.
Sodium benzoate: purchased from ala Ding Shiji (Shanghai) limited.
Disodium EDTA: purchased from ala Ding Shiji (Shanghai) limited.
The acne removing agent disclosed by the invention comprises the following components in parts by mass as shown in table 1.
The mass parts of each component of the conditioner are shown in table 2.
The mass parts of the components of the cleaning agent are shown in table 3.
The acne-removing cleansing composition disclosed by the invention comprises the following components in parts by mass as shown in table 4.
The preparation method of the shower gel comprises the following steps:
S1, adding the composition and the chelating agent into water, heating to 80-85 ℃, stirring and cooling;
S2, after cooling to 40-45 ℃, adding the preservative and the thickener into the S1, stirring and dissolving until the temperature is less than or equal to 38 ℃, and standing for 12 hours.
The mass percentages of the specific components are shown in Table 5.
Note that: the balance is water.
Safety test
Cosmetic irritation evaluation was performed on the acne-removing cleansing body washes of examples 15-21 by using 2015 "cosmetic safety technical Specification" as a reference standard, and the test method was a skin patch test, and 70 persons with ages 16-65 were randomly distributed.
The testing method comprises the following steps: putting the test object into a patch tester with the dosage of 5g, covering the patch tester with the test object on the back or the curved side of the forearm of a subject by using a non-stimulated cloth-based adhesive tape, lightly pressing the patch tester with the palm to uniformly adhere the patch tester on the skin surface for 24 hours, removing the test object for 30 minutes, and observing skin reaction after the indentation disappears. If the result is negative, the observation is carried out again 24 hours and 48 hours after the patch test, respectively.
Evaluation criteria:
Level 0: a negative reaction;
stage 1: suspicious reactions, only weak erythema;
2 stages: weak positive response, erythema, infiltration, edema, and possibly papules;
3 stages: strong positive reaction, erythema, infiltration, edema, papule, and reaction beyond the test area;
4 stages: very strong positive response, marked erythema, severe infiltration, edema, blepharospermia, and response beyond the test area.
Test results: all subjects were negative for skin response.
The test results show that the acne-removing facial cleanser composition and the skin care product bath cream provided by the invention are mild and free of irritation to skin, and are safe to use.
Cytotoxicity test
Human corneal epithelial cells HCEC with stable growth state were taken, and the cell concentration was adjusted to 1X 10 5/mL, and inoculated into 96-well cell culture plates (except outermost peripheral wells and blank wells) at 100. Mu.L per well. 200. Mu.L of PBS was added to the outermost wells of the cell culture plates to reduce evaporation of the medium. Placing the cells in a carbon dioxide incubator, and culturing at 37+/-1 ℃ under the condition that the concentration of CO 2 is 5.0+/-1% until the cell fusion reaches more than 90%. Samples were added at a concentration of 10mg/L, and a blank, sample set, 100. Mu.L per well, was set. And (3) starting to add samples (sample groups) and PBS (blank control), keeping the time interval of adding samples in every two rows consistent, ensuring that the intervention time of each test object to cells is 5 min, sequentially sucking the test objects after 5 min, adding PBS into each hole, and cleaning the test objects for 2 times. The liquid in the hole is sucked by a vacuum suction pump or a discharge gun, and the operation is carefully performed so as not to suck out the living cells to influence the experimental result. 100. Mu.L of complete medium and 10. Mu.L of CCK-8 solution were added to each well, and the wells were placed in an incubator for cultivation for about 2 hours. At 450 nm wavelengths, absorbance (OD) values were measured and cell viability calculated; the results are shown in Table 6.
As can be seen from the results of the experiments in Table 4, the cell viability was maintained at 95% or more. The experiment collocation composition has small influence on HCEC cell viability.
Antibacterial agent for acne bacillus
Referring to WS/T650-2019, 24h fresh bevel cultures of acne bacillus were washed with PBS and diluted to 5.0X10 5CFU/mL-5.0×106 CFU/mL for use using a bacteriostatic ring test.
Preparation of antibacterial tablets: the cut diameter was 5 mm and the thickness was no more than 4 mm pieces of filter paper, each 4 pieces being a set immersed in 10mL of sample solution.
Preparation of negative control plaques: taking samples of the same material, preparing into discs (blocks) with the same size as the test group, and soaking in sterile water.
The acnes suspension with the concentration of 5.0X10 5CFU/mL-5.0×106 CFU/mL is dipped by a sterile cotton swab and evenly smeared on the surface of a proper culture medium flat plate for 3 times. And (3) each time of smearing, the flat plate rotates for 60 degrees, and finally, the cotton swab is smeared around the edge of the flat plate for one circle. The plate was covered and left to dry at room temperature for 5min. 1 bacteria-staining plate is attached to each test, and 4 test pieces, 1 negative control piece and 5 pieces are attached to each plate. The sample piece is stuck on the surface of the flat plate by using sterile forceps, the negative control sample piece is stuck on the center of the flat plate, the test sample piece is stuck on the periphery, and after the sample piece is stuck, the sample piece is lightly pressed by using the sterile forceps, so that the sample piece is clung to the surface of the flat plate. The distance between the centers of the sample pieces is more than 25 mm and the distance between the centers of the sample pieces and the periphery of the flat plate is more than 15 mm. The plate is covered, incubated at 36+ -1deg.C for 16-18 h, and the test is repeated 3 times. The diameter of the inhibition ring (including the patch) is measured by a vernier caliper and recorded, when the inhibition ring is measured, the inhibition ring which grows uniformly and completely in a sterile mode is selected for carrying out the measurement, and the diameter of the inhibition ring is measured by taking the outer edge of the inhibition ring as a boundary.
The negative control sample should not have a bacteriostasis ring, and the test sample has a bacteriostasis effect when the diameter of the bacteriostasis ring is more than 7 mm; and if the diameter of the inhibition ring is less than or equal to 7 mm, judging that the inhibition ring has no inhibition effect. And (3) judging that the test is qualified if the test has an antibacterial effect in 3 repeated tests. See table 7 for specific results.
The results show that: the comparison of the examples and the comparative examples shows that the examples are superior to the comparative examples in bacteriostasis performance, so that the preparation is carried out according to the proportion defined by the invention, and the effect achieved by the invention cannot be achieved by any default. And the default of the comparative example also proves that certain synergistic effect exists between the proportions defined by the invention.
Fourth, percutaneous Water loss (TEWL) test
The transcutaneous water loss (TEWL) is an important parameter in assessing the barrier function of the skin and is indicative of the loss of moisture in the deep dermis through evaporation of the epidermis. The higher the rate of percutaneous loss of water indicates that the more moisture is lost through the skin, the weaker the skin's ability to retain moisture.
The rate of percutaneous water loss is closely related to the hydration of the stratum corneum and is a common indicator reflecting the barrier function of the stratum corneum. In the development process of the cosmetics, the efficacy of the moisturizing cosmetics can be evaluated by testing the TEWL value of skin moisture loss. In addition, the percutaneous water loss rate can also be applied to allergic patch tests, contact dermatitis, physiotherapy, burn and monitoring of new tissues, and whether the protective function of the skin is destroyed can be found in time.
Therefore, the percutaneous water loss rate is an important parameter for evaluating skin health, and has important significance for developing and evaluating cosmetics.
190 Healthy subjects between 18 and 60 years old, with intact persons on the inner side of the arm, were selected for grouping, 10 persons in each group, and 5 men and 5 women in each group, respectively. Sample and blank groups (i.e., negative control group: no test sample) were set, and the test areas were randomly distributed in the area 1cm 2 inside the arm of the volunteer. One area was used with 1g of test product and the other area was blank, as a negative control area, and before the use of the product (T0), 2 hours after the use of the product (T1), the forearm skin percutaneous water loss rate (TEWL) was collected, and the moisturizing effect of the product was evaluated by using the variation difference of the skin index of the product treatment area and the negative control area before and after the use of the product, and the average value was taken, to obtain the following results in table 8.
The experiments show that the shower gel prepared by the application examples 15-21 has good moisturizing effect on skin compared with the shower gel prepared by the comparative examples 23-34, can obviously increase the moisture content of skin horny layer and reduce the moisture loss of skin outside, and fully proves that the shower gel disclosed by the invention scientifically customizes a compound formula aiming at the moisturizing requirement of each layer of skin epidermis, so that the full-effect moisturizing care of reducing the percutaneous water loss rate, promoting the generation of hyaluronic acid, enhancing the internal cell water circulation, strengthening the surface water locking barrier and the like is achieved.
Fifthly, human body sensory test
1. Foam Properties
Reference GB/T13173-91, measured using the Ross-Miles method. 10g of the samples of examples 15-21 and comparative examples 23-34 were weighed, dissolved in 150mg/kg of hard water and fixed to a 1000mL volumetric flask, and the prepared solution was placed in a 40℃constant temperature water bath for 0.5h. After 200mL of the test solution was flowed from a height of 90cm to the surface of 50mL of the same test solution at the bottom of the graduated cylinder at 40℃and the liquid collided to generate foam, a stopwatch was immediately started and the corresponding foam height of the system at 30s and 5min was recorded. The foaming capacity is corresponding to the foam height (H α) corresponding to 30s, and the stability of the foam is corresponding to the ratio (H β/Hα) of the corresponding foam height (H β) to H α after 5 min. See table 9 for specific test data.
2. Usage sense test
Aiming at the use performances of mildness, moistening, cleanliness, itching relieving and the like of the shower gel, the effect evaluation is carried out after 10 volunteers use the shower gel, the scoring standard adopts 10 minutes, the higher the score is, the better the effect is, and the statistical result is averaged. See table 9 for specific test data.
The results show that: comparison of examples with comparative examples shows that the examples are superior to the comparative examples in terms of foam properties, and are significantly superior to the comparative examples in terms of foam height or foam stability, and thus the preparation at the ratios defined in the present invention does not achieve the effects achieved by the present invention by any default. And the default of the comparative example also proves that certain synergistic effect exists between the proportions defined by the invention.
The results of the examples and the comparative examples show that the examples are superior to the comparative examples in terms of mildness, moisturization, cleanliness and the presence or absence of skin itch, so that the effect achieved by the present invention cannot be achieved by any default when the preparation is carried out in the proportions defined by the present invention. And the default of the comparative example also proves that certain synergistic effect exists between the proportions defined by the invention.
The embodiments described above are some, but not all embodiments of the application. The detailed description of the embodiments of the application is not intended to limit the scope of the application, as claimed, but is merely representative of selected embodiments of the application. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
Claims (4)
1. An acne-removing cleansing composition is characterized in that: the composition comprises the following components in parts by mass: 0.5-1.5 parts of acne removing agent; 0.1-1 part of conditioner; 24-30 parts of a cleaning agent; wherein,
The acne removing agent comprises the following components in parts by mass:
5.5-7.5 parts of salicylic acid;
0.1-1 part of cyclodextrin;
0.5-1 part of wild chrysanthemum extract;
0.5-1 part of dandelion extract;
0.5-1 part of paeonia lactiflora root extract;
The conditioner comprises the following components in parts by mass:
0.1-1 part of chamomile extract;
0.1-1 part of Malva sylvestris extract;
1.5-2 parts of aloe vera leaf juice;
3-4 parts of silver ear fruiting body extract;
0.04-0.05 part of xylitol-based glucoside;
0.03-0.05 part of xylitol;
The cleaning agent comprises the following components in parts by mass:
10-11 parts of laureth ammonium sulfate;
1-1.1 parts of cocamidopropyl betaine;
0.8-1 part of sodium lauroyl sarcosinate;
0.94-0.97 parts of lauroyl amphoacetate sodium;
0.3-0.4 part of cocoyl methyl taurine sodium;
0.5-0.7 part of decyl glucoside.
2. An acne-removing cleansing body wash characterized in that it comprises 20-45wt% of the composition according to claim 1.
3. The body wash of claim 2, further comprising 0.7wt% to 0.9wt% of a preservative, wherein the preservative is at least one of phenoxyethanol and sodium benzoate; 2-4wt% of a thickening agent, wherein the thickening agent is sodium chloride; 0.5-1.5 wt% of chelating agent, wherein the chelating agent is disodium EDTA.
4. A body wash according to claim 3, characterized in that the preparation process is as follows:
S1, adding a cleaning agent and a chelating agent into water, heating to 80-85 ℃, stirring, and cooling;
S2, adding the acne removing agent, the conditioner, the preservative and the thickener into the S1 after cooling to 40-45 ℃, stirring and dissolving until the temperature is less than or equal to 38 ℃, and standing for 12 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410551852.3A CN118121524B (en) | 2024-05-07 | 2024-05-07 | Acne-removing facial cleanser composition and bath foam thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410551852.3A CN118121524B (en) | 2024-05-07 | 2024-05-07 | Acne-removing facial cleanser composition and bath foam thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN118121524A CN118121524A (en) | 2024-06-04 |
| CN118121524B true CN118121524B (en) | 2024-07-02 |
Family
ID=91230547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410551852.3A Active CN118121524B (en) | 2024-05-07 | 2024-05-07 | Acne-removing facial cleanser composition and bath foam thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118121524B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118845536A (en) * | 2024-07-03 | 2024-10-29 | 广州汇创化妆品有限公司 | Acne-removing scrub shower gel and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107789278A (en) * | 2017-10-31 | 2018-03-13 | 思拓科（上海）生物科技股份有限公司 | Organic baby bath dew |
| CN109730954A (en) * | 2019-02-23 | 2019-05-10 | 中美杜克(广州)护肤研究中心(普通合伙) | It is quick with town, releive, maintenance, the skin care item and preparation method thereof for improving sebum film effect |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009203170A (en) * | 2008-02-26 | 2009-09-10 | Shoichi Nakamura | Bath agent |
| CN109998961A (en) * | 2019-05-17 | 2019-07-12 | 菏泽龙池生物科技有限公司 | A kind of moist skin makeup body lotion and preparation method thereof |
| CN113143834B (en) * | 2021-05-24 | 2023-07-04 | 建昌帮药业有限公司 | Acne-removing skin care composition and preparation method thereof |
-
2024
- 2024-05-07 CN CN202410551852.3A patent/CN118121524B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107789278A (en) * | 2017-10-31 | 2018-03-13 | 思拓科（上海）生物科技股份有限公司 | Organic baby bath dew |
| CN109730954A (en) * | 2019-02-23 | 2019-05-10 | 中美杜克(广州)护肤研究中心(普通合伙) | It is quick with town, releive, maintenance, the skin care item and preparation method thereof for improving sebum film effect |
Also Published As
| Publication number | Publication date |
|---|---|
| CN118121524A (en) | 2024-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110755331B (en) | Antibacterial infant washing and caring preparation and application thereof | |
| CN105232442A (en) | A kind of plant antioxidant amino acid cleanser and preparation method thereof | |
| CN111265439A (en) | Oil-control, dandruff-removing and itching-relieving shampoo and preparation method thereof | |
| CN118121524B (en) | Acne-removing facial cleanser composition and bath foam thereof | |
| CN108113894A (en) | A kind of infant's activity milky lotion and preparation method thereof | |
| CN107982135A (en) | A kind of shampoo and preparation method thereof | |
| CN110742819A (en) | Amino acid facial cleansing honey | |
| CN113491651A (en) | Soothing and repairing mask essence containing camellia extract and preparation method and application thereof | |
| CN104434642B (en) | An after-sun repairing, whitening and moisturizing gel and its preparation method | |
| CN109453083B (en) | Moisturizing and allergy-relieving composition and application thereof | |
| CN110755307A (en) | Salt lake black mud active mask and preparation method thereof | |
| WO2020244166A1 (en) | Multi-biological enzyme medical restoring face mask and preparation method thereof | |
| CN108498390A (en) | A kind of Tibetan book on Chinese herbal medicine extract and the preparation method and application thereof for treating acne | |
| CN113278477A (en) | Whitening, moisturizing, moistening and bacteriostatic bath soap and preparation method thereof | |
| CN112402308A (en) | Multi-effect relieving moisturizing lotion and preparation method thereof | |
| CN111297780A (en) | Long charcoal cleansing water-permeable moistening mask | |
| RU2671511C1 (en) | Cosmetic composition for hair and head skin care (options) | |
| CN109481382A (en) | A kind of moisture-regulating agent of the water containing bermuda lily and preparation method thereof and facial mask application | |
| CN113476385A (en) | A bath gel containing multiple natural plant effective components for whitening skin, benefiting skin and repairing skin, and its preparation method | |
| KR100977063B1 (en) | Human Cleanser Composition with Herbal Ingredients | |
| CN108186440A (en) | Can antibiotic skin-care Chinese medicinal plant shower cream and its preparation method and application | |
| CN115252475B (en) | Skin-moistening and cleaning composition, bath foam and preparation method thereof | |
| CN115590798B (en) | Double-component bath lotion with anti-allergy and skin tendering effects and preparation method thereof | |
| KR20100094109A (en) | Functional skin lotion including date | |
| CN118615169A (en) | A kind of blue salt moisturizing composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |